Delta-aminolevulinic acid-mediated photosensitization of prostate cell lines: Implication for photodynamic therapy of prostate cancer

Pradip Chakrabarti, Eduardo Orihuela, Norman Egger, Durwood E. Neal, Rama Gangula, Adekunle Adesokun, Massoud Motamedi

Research output: Contribution to journalArticlepeer-review

13 Scopus citations


BACKGROUND. Delta-aminolevulinic acid (ALA)-mediated photodynamic therapy (PDT) is currently being investigated for the treatment of prostate diseases. In this study, we evaluate 1) the in vitro production of protoporphyrin IX (PPIX) (the active photosensitizing agent of ALA-mediated PDT) by two different prostate cancer cell lines (LNCaP and Pc-3) and a benign, modified, prostatic cell line (TP-2), and 2) the extent of PDT- induced cell injury, as determined by electron microscopy (EM) and cell survival. METHODS. The cell lines were assigned into four treatment groups: group 1, control, no ALA and no light irradiation; group 2, dark control, ALA only; group 3, light control, radiation only; and group 4, PDT, ALA followed by irradiation (630 nm, 3 joules/cm2). The experiments were performed in triplicate. ALA concentration was 50 μg/ml of media in all instances. RESULTS. Following incubation with ALA, PPIX production was significantly increased in the three cell lines studied, and more notably in the PC-3 cell line. Compared to controls, EM and cell survival studies demonstrated significant mitochondrial damage and decreased survival, respectively, in the cells treated with PDT. This was also more evident in the PC-3 cell line. CONCLUSIONS. Our results demonstrate that prostate cells differ in their response to ALA-mediated PDT. This response appears to depend on the intracellular production of PPIX and the cell type, i.e., on the functional and structural characteristics of the cell mitochondria. In addition, our results suggest that PDT might be effective at killing prostate cancer cells.

Original languageEnglish (US)
Pages (from-to)211-218
Number of pages8
Issue number4
StatePublished - Sep 1 1998


  • Delta-aminolevulinic acid
  • LNCaP
  • PC- 3
  • Photodynamic therapy
  • Prostate cancer
  • TP-2 cell lines

ASJC Scopus subject areas

  • Oncology
  • Urology


Dive into the research topics of 'Delta-aminolevulinic acid-mediated photosensitization of prostate cell lines: Implication for photodynamic therapy of prostate cancer'. Together they form a unique fingerprint.

Cite this